Family Nurture Intervention (FNI) for Mother-infant Bonding during COVID-19
Trial Summary
What is the purpose of this trial?
This study will assess whether the promotion of emotional exchange between mother and infant during the first four months of life improves primarily mother-child early relational health (ERH) and secondarily child neurodevelopmental and maternal mental health outcomes. In prior research on preterm infants, a similar intervention demonstrated increased quality of maternal caregiving behaviors and significant improvements in premature infants' neurodevelopment across multiple domains, including social-relatedness and attention problems. The goal of the emotional exchange intervention is to help mothers provide appropriate stimulation crucial for social, emotional, and neurobehavioral development, by helping the mother and child become attuned, or 'in sync', with each other. Measures of ERH, such as bonding, maternal sensitivity, and mother-child emotional connection will be compared between two groups: one receiving newborn parenting education and the other undergoing facilitated emotional exchange. Assessments will involve videos of mother-infant interactions during each intervention session and follow-up surveys conducted as part of a linked Institutional Review Board-approved study. Data collected in this study will contribute to understanding the underlying mechanisms of mother-infant interactions and their role in shaping optimal neurodevelopmental trajectories for infants and maternal mental health.
Do I have to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on mother-infant interactions rather than medication use.
What data supports the effectiveness of the treatment Family Nurture Intervention (FNI) for mother-infant bonding during COVID-19?
Is Family Nurture Intervention (FNI) safe for use in humans?
How is the Family Nurture Intervention (FNI) treatment different from other treatments for mother-infant bonding during COVID-19?
Family Nurture Intervention (FNI) is unique because it focuses on creating an emotional connection between mothers and their infants in the NICU through calming sessions that include scent cloth exchange, vocal soothing, and skin-to-skin contact. This approach is novel as it addresses both maternal and infant needs simultaneously, aiming to improve neurodevelopmental outcomes and reduce the risk of long-term behavioral issues.12346
Research Team
Dani Dumitriu, MD, PhD
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for mothers with newborns born between 37 and 40 weeks +6 days, who speak English or Spanish, and agree to participate in linked studies. Excluded are infants needing special care due to anomalies, those advised against by physicians due to health concerns or maternal history of substance abuse/psychosis, multiples like twins, and mothers unwilling to be recorded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Session
Initial study visit occurs in the postpartum unit before discharge, introducing the intervention
Intervention
Weekly sessions for the first four weeks, then monthly until the infant is four months old, focusing on emotional exchange or newborn care
Follow-up
Participants are monitored for safety and effectiveness after treatment, including video recordings of mother-infant interactions
Treatment Details
Interventions
- Family Nurture Intervention (FNI)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor